A recent KPMG global tech survey revealed that 73% of tech function leaders in the life sciences industry believe artificial intelligence (AI) will revolutionize industry practices.
The report is based on a 2024 survey of approximately 2,450 technology leaders, including 123 senior life sciences technology function leaders from 26 countries.
Life sciences organizations are focusing on digital transformation to enhance efficiency and create new business models, with 63% citing risk aversion by senior leadership as a hindrance to digital transformation journeys.
Key findings also show that 59% of tech leaders believe their decision-making processes result in valuable outcomes, and the life sciences sector is prioritizing investments in edge computing, quantum computing, VR/AR/XR, and cyber security.